Technology & Corporate Earnings
UiPath (PATH) reported its first quarter fiscal 2026 financial results, as detailed in their announcement, marking an important update in the enterprise software segment.
Microchip Technology (MCHP) raised its financial guidance for sales and EPS for the first quarter of fiscal 2026, a move that reflects evolving semiconductor demand, as noted in their update.
Dell Technologies (DELL) released its Q1 fiscal 2026 financial results, offering fresh insights into its strategic performance.
NetApp (NTAP) posted record results for the fourth quarter and fiscal year 2025, reinforcing its market position ahead of investor expectations.
Zscaler (ZS) shared its third quarter fiscal 2025 financial results, demonstrating strength in cloud security and digital transformation.
Costco Wholesale Corporation (COST) reported its third quarter and year-to-date operating results for fiscal 2025, a key indicator for retail momentum, according to their release.
Loop Industries (LOOP) reported its fourth quarter and full year fiscal 2025 results while providing an update on key business developments, reflecting a continued focus on sustainable technologies. See the full report.
Consumer & Retail
Ulta Beauty (ULTA) announced its first quarter fiscal 2025 results, reinforcing its status as a leader in the retail beauty space.
Celebrity Cruises (RCL) is investing over $250 million to modernize its Solstice Series ships, rejuvenating its fleet with state-of-the-art guest experiences.
Automotive, Energy & Industrial
Li Auto Inc. (LI) reported its unaudited Q1 2025 financial results, offering vital insights into its evolving performance.
TotalEnergies (TTE) divested its non-operated interest in Nigeria’s Bonga Field, a move that streamlines its asset portfolio.
Plug Power (PLUG) set a U.S. production record at its Georgia hydrogen plant, showcasing breakthroughs in clean energy technology.
Energy Transfer (ET) secured a major LNG supply agreement with Kyushu Electric Power Company, emphasizing a robust energy strategy.
NGL Energy Partners LP (NGL) announced its fourth quarter and full year fiscal 2025 financial results along with guidance for fiscal 2026, underscoring its market outlook amid volatility. See the full details here.
Port Arthur LNG (SRE) Phase 2 received non-FTA export authorization, a significant regulatory nod that could bolster future LNG export activity and market confidence.
Biotechnology & Healthcare
Illumina (ILMN) unveiled PromoterAI, a groundbreaking algorithm designed to accelerate insights for rare disease diagnosis.
Beam Therapeutics (BEAM) received U.S. FDA orphan drug designation for BEAM-302, a promising treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Telomir Pharmaceuticals (TELO) confirmed that its Telomir-1 restored vision and retinal structure in an AMD animal model using FDA-recognized surrogate endpoints, marking a potential breakthrough in vision care.
Danaher (AZN) announced a diagnostic development and commercialization partnership aimed at scaling precision medicine, a strategic move that could transform diagnostic practices. More information is available in their announcement.
Cytek Biosciences (CTKB) is setting the new standard for full spectrum flow cytometry with its new Cytek Aurora™ Evo Flow Cytometer, promising enhanced research capabilities and multiplexing performance.
Lilly (LLY) announced details of its presentations at the American Diabetes Association's 85th Scientific Sessions, underlining its ongoing commitment to diabetes research and patient care.
Corporate Actions & Strategic Moves
Wells Fargo (WFC) entered into an agreement to sell its rail equipment assets, a strategic move that complements its recent operational adjustments. Learn more in the full report.
Virtu Financial (VIRT) announced the transfer of its common stock listing to the New York Stock Exchange, a maneuver expected to enhance its market profile. The official statement details the move.
C3 AI (AI) saw its U.S. Air Force Rapid Sustainment Office contract award increase to $450 million, reinforcing its growing role in advanced defense technology.
American Integrity Insurance Group, Inc. (AII) announced the full placement of its 2025-2026 CAT XOL Reinsurance Program, a key strategic capital move that underscores its risk management and growth strategy. Read more in their announcement.
